University Hospital Zurich, Visceral Surgery
Welcome,         Profile    Billing    Logout  
 23 Trials 
8 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Stupp, Roger
SONOBIRD, NCT05902169: Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Recruiting
3
560
Europe, US
SonoCloud-9 (SC9), Carboplatin, CycloButane DiCarboxylic Acid (CBDCA), Lomustine, 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU), Temozolomide, Temodal
CarThera
Glioblastoma, Recurrent Glioblastoma, GBM
01/28
06/28
NCT05864534: Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma

Recruiting
2
25
US
Balstilimab, BAL, Botensilimab, BOT, Liposomal Doxorubicin, DOX, Sonocloud-9 (SC-9), SC-9
Northwestern University, Agenus Inc., CarThera
Newly Diagnosed Glioblastoma, Glioblastoma, Isocitric Dehydrogenase (IDH)-Wildtype, Gliosarcoma, Glioblastoma Multiforme
05/26
08/26
SC9/ABX, NCT04528680: Ultrasound-based Blood-brain Barrier Opening and Albumin-bound Paclitaxel and Carboplatin for Recurrent Glioblastoma

Recruiting
1/2
57
US
Sonication for opening of blood-brain barrier, SonoCloud-9 device, SC-9, Chemotherapy, albumin-bound paclitaxel, Abraxane®, ABX, Chemotherapy, carboplatin, Paraplatin
Northwestern University, CarThera, Bristol-Myers Squibb, Lantheus Medical Imaging
Glioblastoma, Gliosarcoma, GBM, Glioblastoma Multiforme, Glioblastoma, IDH-wildtype, Recurrent Glioblastoma
09/24
09/25
TNG908-C101, NCT05275478 / 2021-005605-27: Safety and Tolerability of TNG908 in Patients With MTAP-deleted Solid Tumors

Active, not recruiting
1/2
192
Europe, US
TNG908
Tango Therapeutics, Inc., Tango Therapeutics, Inc.
Locally Advanced Solid Tumor
04/25
09/25
FRONTIER, NCT05303467: A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM

Active, not recruiting
1
12
US
TheraSphere GBM, TheraSphere™ GBM Y-90 Glass Microspheres (TheraSphere GBM)
Boston Scientific Corporation
Glioblastoma Multiforme, Recurrent Glioblastoma
12/24
06/25
ReSPECT-LM, NCT05034497: Intraventricular Administration of Rhenium-186 NanoLiposome for Leptomeningeal Metastases

Recruiting
1
18
US
186RNL, Rhenium-186 NanoLiposome
Plus Therapeutics
Leptomeningeal Metastasis
12/25
06/26
FORESEE, NCT05414123: A Therapy Treatment Response Trial in Patients With Leptomeningeal Metastases ((LM) Using CNSide

Terminated
N/A
40
US
CNSide
Biocept, Inc., ICON plc
Leptomeningeal Metastasis, Leptomeningeal Disease, Leptomeningeal Neoplasms, Breast Cancer, Non-Small Cell Lung Cancer
10/23
10/23
Samaras, Panagiotis
CARTePRO, NCT05354973: ePRO for the Timely Detection of Side Effects in Cancer Patients Undergoing CAR T Immunotherapy

Recruiting
N/A
11
Europe
Consilium CareTM
Stiftung Swiss Tumor Institute, Klinik Hirslanden, Zurich, Palleos Healthcare GmbH
Patient Reported Outcome Measures, CAR T-Cell Therapy
04/25
04/25

Download Options